Immunology

Research indicates wider benefit to AstraZeneca vaccine

A review of the COVID-19 vaccine trials indicate that adenovirus vectored vaccines may have non-specific protective effects resulting in significantly reduced all-cause mortality and non-COVID deaths, compared with mRNA based ...

Diseases, Conditions, Syndromes

Moderna reports positive results for RSV vaccine

US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.

Diseases, Conditions, Syndromes

COVID-19 vaccine gives substantial protection against reinfection

Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup ...

page 5 from 33